Description
LosartanisaninhibitoroftheangiotensinIItype1(AT1)receptorthatexhibitsantihypertensive,anti-fibrotic,andnephroprotectiveactivities.Inanimalmodelsofobstructivenephropathy,losartandecreaseslevelsofα-SMAandcollagentype1andinhibitsphosphorylationofSTAT3,suppressingrenaltubularfibrosis.Losartanalsoinhibitstheendothelial-to-mesenchymaltransitionthroughindirectinhibitionofERKactivation,potentiallyshowinganti-fibroticbenefitaftermyocardialinfarction.
References
HeP,LiD,ZhangB.Losartanattenuatesrenalinterstitialfibrosisandtubularcellapoptosisinaratmodelofobstructivenephropathy.MolMedRep.2014Aug;10(2):638-44.PMID:24912579.
Wylie-SearsJ,LevineRA,BischoffJ.Losartaninhibitsendothelial-to-mesenchymaltransformationinmitralvalveendothelialcellsbyblockingtransforminggrowthfactor-β-inducedphosphorylationofERK.BiochemBiophysResCommun.2014Apr18;446(4):870-5.PMID:24632204.
GibsonTJ.Hypertension,itstreatment,hyperuricaemiaandgout.CurrOpinRheumatol.2013Mar;25(2):217-22.PMID:23370375.
ApostolakisS,KrambovitisE,VlataZ,etal.CX3CR1receptorisup-regulatedinmonocytesofcoronaryarterydiseasedpatients:impactofpre-inflammatorystimuliandrenin-angiotensinsystemmodulators.ThrombRes.2007;121(3):387-395.PMID:17521710.
KosekiN,DeguchiJ,YamashitaA,etal.Establishmentfoanovelexperimentalprotocolfordrug-inducedseizureliABIlityscreeningbasedonalocomotoractivityassayinzebrafish.JToxicolSci.2014Aug;39(4):579-600.PMID:25056783.
NagataT,FukuzawaT,TakedaM,etal.Tofogliflozin,anovelsodium-glucoseco-transporter2inhibitor,improvesrenalandpancreaticfunctionindb/dbmice.BrJPharmacol.2013Oct;170(3):519-531.PMID:23751087.